Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $536.70 USD
Change Today -1.30 / -0.24%
Volume 507.8K
REGN On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Marc Tessier-Lavigne Ph.D.

Independent Director, Chairman of Compensation Committee and Member of Technology Committee,Regeneron Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 76 board members in 7 different organizations across 7 different industries.

See Board Relationships


Dr. Marc Tessier-Lavigne, Ph.D. has been the President of The Rockefeller University since 2011, where Dr. Tessier-Lavigne also serves as a professor and head of the laboratory of brain development and repair. He is a Co-founder of Renovis Inc. He joined The Rockefeller University in 2011. He served as the Chief Scientific Officer and Executive Vice President of Research of Genentech, Inc. He served as an Executive Vice President of Research Drug Discovery of Genentech ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-847-7000
Fax: --

Board Members Memberships*

Founder and Chairman of The Board
Independent Director, Chairman of Compensation Committee and Member of Technology Committee
Chairman and Chairman of Science & Technology Committee
Director, Chairman of Scientific Committee and Member of Compensation Committee


Bachelor's Degree
McGill University
Bachelor's Degree
University of Oxford
Doctorate 1987
University College London

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $536.70 USD -1.30


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at